super gut glp 1 booster GLP-1 Daily Support Supergut The Gut Healthy GLP-1

Several randomized controlled trials have demonstrated the benefits of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on ischemic stroke in patients with diabetes

Conclusion GLP-1RAs show significant promise as a potential disease-modifying therapy for neurodegenerative and inflammatory eye diseases, acting through both systemic metabolic improvements and direct ocular mechanisms, representing a paradigm shift beyond their metabolic indications.

Key Findings: - Increased risk of going over recommended weight gain limits - Higher chances of preterm birth (from 13% to 17%) - Rising cases of gestational diabetes (15% to 20%) - Nearly half faced high blood pressure issues While baby sizes and C-section rates remained similar, the impact on maternal health is significant

GLP-1 is an essential hormone for regulating appetite and blood sugar

for these drugs in 2023 (the latest year I found data for) was $71,700,000,000 (yes, 71.7 billion

In this attempt, observational and experimental studies and review articles will be gathered from leading scientists in the field of diabetes mellitus.Areas to be covered in this Research Topic may include, but are not limited to:- Studies on the effect of SGLT2 inhibitors or GLP-1 receptor agonists on testosterone and gonadotropins in male patients with diabetes mellitus and hypogonadism- Studies on the effect of SGLT2 inhibitors or GLP-1 receptor agonists on testosterone gonadotropins in female patients with diabetes mellitus and p...